Intellipharmaceutics Provides Timing of First Quarter 2020 Results

Author's Avatar
Apr 10, 2020
Article's Main Image

TORONTO, ON / ACCESSWIRE / April 9, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF);(TSX:IPCI, Financial) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, is providing an update on timing of the release of its first-quarter financial results for the three months ended February 29, 2020.